neurogenic orthostatic hypotension

Theravance Narrows Focus to Multiple System Atrophy Subset Following Mixed Results
BioSpace
Tue, 04/5/22 - 11:04 am
Theravance
ampreloxetine
multiple system atrophy
neurogenic orthostatic hypotension
Lundbeck Completes Acquisition of Chelsea Therapeutics; NORTHERA™ (droxidopa) is expected to be available to patients in the U.S. during the fall of this year
Yahoo
Tue, 06/24/14 - 10:26 am
Lundbeck
Chelsea Therapeutics
Northera
neurogenic orthostatic hypotension
Chelsea Therapeutics Wins FDA Approval For Northera
TheStreet.com
Tue, 02/18/14 - 05:42 pm
FDA
Northera
Chelsea Therapeutics
neurogenic orthostatic hypotension
Chelsea Wins U.S. Panel’s Backing for Northera
Bloomberg
Wed, 01/15/14 - 09:29 am
Chelsea Therapeutics
FDA
advisory panels
Northera
neurogenic orthostatic hypotension
Chelsea Therapeutics: Northera FDA Panel Live Blog
TheStreet.com
Tue, 01/14/14 - 09:09 am
FDA
advisory panels
Chelsea Therapeutics
Northera
neurogenic orthostatic hypotension
Long-term efficacy of Chelsea drug may pose problems for FDA
Yahoo/Reuters
Fri, 01/10/14 - 10:07 am
Chelsea Therapeutics
FDA
Northera
Droxidopa
neurogenic orthostatic hypotension
Chelsea's NDA for Northera Accepted
Yahoo/Zacks
Sat, 07/20/13 - 11:09 am
Chelsea Therapeutics
Northera
neurogenic orthostatic hypotension
What To Do With Chelsea After The FDA Snub
Seeking Alpha
Sat, 03/31/12 - 11:53 am
Chelsea Therapeutics
Northera
neurogenic orthostatic hypotension
FDA rejects Chelsea's Northera, demands additional study data
Fierce Biotech
Thu, 03/29/12 - 10:26 am
FDA
Northera
Chelsea Therapeutics
neurogenic orthostatic hypotension
Chelsea Therapeutics gets patent protection on hypotension drug
Reuters
Thu, 12/15/11 - 09:46 am
Chelsea Therapeutics
hypotension
Northera
neurogenic orthostatic hypotension
Parkinson's Disease
Chelsea Therapeutics International to ask for FDA approval of Northera in the 3rd-quarter
Yahoo/AP
Mon, 04/18/11 - 04:55 pm
Chelsea Therapeutics
FDA
Northera
neurogenic orthostatic hypotension